Successful plasma exchange in type 1 leprosy reversal reaction F LUCHT, G RIFLE, H PORTIER, J M CHALOPIN, J BONHOMME Abstract A 24 year old man admitted to hospital with borderline lepromatous leprosy was treated with rifampicin, dapsone, and clofazimine. After four months he developed a reversal reaction and the diagnosis was modified to borderline tuberculoid leprosy. The dose of clofazimine was raised and prednisolone added to the regimen without any symptomatic response. His condition improved dramatically after five plasma exchanges on five successive days.
Introduction
The clinical features of leprosy may alter as the patient's immune response to the disease alters. An increase in immunity -termed reversal-is common after treatment, and the disease moves towards the tuberculoid pole. In the type 1 leprosy reversal reaction severe nerve lesions may occur' and are usually controlled by clofazimine and steroids. The failure of this combination in one patient led us to try plasma exchanges.
Case report
A 24 year old black Senegalese man was first admitted in September 1983 with multiple hypoaesthetic bilateral, symmetrical hypopigmented macules on the neck, face, back, arms, and thighs and nodules on the earlobes. He On 7 January 1984 the dosage of clofazimine was increased to 400 mg daily and prednisolone 1 mg/kg was introduced; dosages of rifampicin and dapsone remained as before. His condition did not improve, and the lesions remained painful. From 25 January, on five successive days, he was given five plasma exchanges. At each procedure 150% of theoretical plasma volume was exchanged for diluted albumin. On the third day his temperature was normal, and by the sixth day the oedema had resolved and the pain disappeared. Nerve paralysis was only slightly improved. Despite antibiotics, clofazimine, and steroids, which were continued in unaltered dosage until 10 March, on 17 February he developed a second, identical type 1 leprosy reversal reaction. Plasma exchange as before had a similar effect, after which his condition continued to improve.
Discussion
Plasma exchange has been used successfully in type 2 reactions (erythema nodosum leprosum) resulting from deposition of immune complexes,2 but to our knowledge it has never been used in type 1 reactions. Although results in a single case must be interpreted carefully, such a close relation between plasma exchange and clinical improvement suggests a causal relation.
Usually type 1 leprosy reversal reactions are controlled by clofazimine and steroids. The failure of these drugs in this case may have been due to the fact that rifampicin and dapsone were given in high dosages for a long period. In type 1 leprosy reversal reactions there is an increased phytohaemagglutinin lymphocyte response, which might be explained by a decrease in mycobacterial load in macrophages due to effective antileprosy treatment3 or by the presence in the plasma of such patients of a factor augmenting the lymphocytic response to phytohaemagglutinin in vitro.4 The removal of such a factor might explain, at least in part, the beneficial effect of plasma exchange and the observed variations in numbers of T4 cells and in the ratio of T4 to T8 cells ( figure) . Why the first increase in the ratio of T4 to T8 cells was followed by a type 1 leprosy reversal reaction and the second was not remains unclear. This observation may serve as an alternative explanation for the possible effect of plasma exchange on cell mediated immunity to the one previously suggested. 
